Washington, DC, July 30, 2021 – AARDA sent a letter to key members of Congress with the undersigned 50+ patient groups on the importance of drug pricing policy concerns, priorities, and solutions for individuals living with autoimmune disease.
At a high-level, the letter focuses on the following concerns;
We also suggest patient-focused policy solutions;
Specifically, the letter went to House and Senate leadership, House E&C, Senate HELP, and Senate Finance, and the group of 10 democrats who wrote a letter to Speaker Pelosi regarding concerns for certain drug pricing policies under HR3.
American Autoimmune Related Diseases Association (AARDA) is the nation’s only nonprofit organization dedicated to bringing a national focus to autoimmunity as a category of disease and a major women’s health issue and promoting a collaborative research effort in order to find better treatments and a cure for all autoimmune diseases.